SB-728mR-T
SB-728mR-1401
Phase 2 gene_therapy completed
Quick answer
SB-728mR-T for Human Immunodeficiency Virus (HIV) is a Phase 2 program (gene_therapy) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- Human Immunodeficiency Virus (HIV)
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- completed